Related Experiment Videos
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes
A Burlina1, M Plebani, S Secchiero
1Centro di Ricerca Biomedica della Regione Veneto, Università di Padova, Italy.
Clinical Biochemistry
|October 1, 1991
Summary
A new method using wheat-germ lectin accurately quantifies bone alkaline phosphatase (ALP). This simple assay is suitable for routine bone ALP determination and screening for bone metastases.
Area of Science:
- Biochemistry
- Clinical Chemistry
Background:
- Alkaline phosphatase (ALP) exists in multiple isoenzyme forms.
- Accurate quantification of bone ALP is crucial for diagnosing bone diseases and detecting metastases.
Purpose of the Study:
- To evaluate a novel wheat-germ lectin precipitation method for quantifying bone isoenzyme of alkaline phosphatase (ALP).
- To assess the method's analytical performance, clinical applicability, and suitability for routine use.
Main Methods:
- Wheat-germ lectin was used to precipitate the bone isoenzyme of ALP.
- Assay precision, linearity, and correlation with an affinity electrophoretic method were assessed.
- Reference ranges were established in healthy adults, children, and adolescents.
- Clinical applicability was evaluated in various patient groups, including those with hepatobiliary diseases and metastases.
Main Results:
- The method demonstrated good precision (CVs 3.2-11.5%) and linearity up to 1100 U/L.
- A high coefficient of correlation (r = 0.886) was observed when compared to an affinity electrophoretic method.
- The assay was easily adapted for automated kinetic measurement.
- The method proved suitable for routine bone ALP determination and screening for bone metastases.
Conclusions:
- The wheat-germ lectin precipitation method is a technically simple and analytically sound approach for quantifying bone ALP.
- This method offers a viable alternative to heat-inactivation procedures for routine clinical use.
- It is effective for both general bone ALP measurement and the specific screening of bone metastases.